Ceftriaxone-resistant Neisseria gonorrhoeae detected in England, 2015–24: an observational analysis
Journal of Antimicrobial Chemotherapy · 02.12.2024 · 79 (12) · 3332-3339
DOI: 10.1093/jac/dkae369 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 17.10.2024. Verfasst von Helen Fifer und 27 weiteren Autor:innen. Beteiligte Einrichtung: Blood Safety, Hepatitis, STI & HIV Division, United Kingdom Health Security Agency, London, UK. Hauptthemen laut MEDLINE: Neisseria gonorrhoeae, Ceftriaxone, Gonorrhea, Anti-Bacterial Agents. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: United Kingdom Health Security Agency.
Abstract (Originalsprache)
Objectives
Since June 2022, there has been a rise in the number of ceftriaxone-resistant Neisseria gonorrhoeae cases detected in England (n = 15), of which a third were XDR. We describe the demographic and clinical details of the recent cases and investigate the phenotypic and molecular characteristics of the isolates. For a comprehensive overview, we also reviewed 16 ceftriaxone-resistant cases previously identified in England since December 2015 and performed a global genomic comparison of all publicly available ceftriaxone-resistant N. gonorrhoeae strains with mosaic penA alleles.
Methods
All N. gonorrhoeae isolates resistant to ceftriaxone (MIC > 0.125 mg/L) were whole-genome sequenced and compared with 142 global sequences of ceftriaxone-resistant N. gonorrhoeae. Demographic, behavioural and clinical data were collected.
Results
All cases were heterosexual, and most infections were associated with travel from the Asia-Pacific region. However, some had not travelled outside England within the previous few months. There were no ceftriaxone genital treatment failures, but three of five pharyngeal infections and the only rectal infection failed treatment. The isolates represented 13 different MLST STs, and most had the mosaic penA-60.001 allele. The global genomes clustered into eight major phylogroups, with regional associations. All XDR isolates belonged to the same phylogroup, represented by MLST ST16406.
Conclusions
Most cases of ceftriaxone-resistant N. gonorrhoeae detected in England were associated with travel from the Asia-Pacific region. All genital infections were successfully treated with ceftriaxone, but there were extragenital treatment failures. Ceftriaxone resistance continues to be associated with the penA-60.001 allele within multiple genetic backgrounds and with widespread dissemination in the Asia-Pacific region.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Blood Safety, Hepatitis, STI & HIV Division, United Kingdom Health Security Agency, London, UK.
- Specialised Microbiology and Laboratories, United Kingdom Health Security Agency, London, UK.
- Hillingdon Integrated Sexual and Reproductive Health, London North West University Healthcare NHS Trust, London, UK.
- Sexual Health Department, University Hospitals Plymouth NHS Trust, Plymouth, UK.
- Genito-Urinary Medicine, Barts Health NHS Trust, London, UK.
- Directorate of Sexual Health and HIV Medicine, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.
ORCID-Profile: Helen Fifer, Gurmit Jagjit Singh, John Evans-Jones, Kenny Poon, Rachel Pitt-Kendall, James E C Johnson, Neil Woodford, Michelle Cole
Förderung
- United Kingdom Health Security Agency
Zitieren
APA
Fifer, H., Doumith, M., Rubinstein, L., Mitchell, L., Wallis, M., Singh, S., Jagjit Singh, G., Rayment, M., Evans-Jones, J., Blume, A., Dosekun, O., Poon, K., Nori, A., Day, M., Pitt-Kendall, R., Sun, S., Narayanan, P., Callan, E., Vickers, A., …, & Cole, M. (2024). Ceftriaxone-resistant Neisseria gonorrhoeae detected in England, 2015–24: an observational analysis. Journal of Antimicrobial Chemotherapy, 79(12), 3332-3339. https://doi.org/10.1093/jac/dkae369
Vancouver
Fifer H, Doumith M, Rubinstein L, Mitchell L, Wallis M, Singh S, et al. Ceftriaxone-resistant Neisseria gonorrhoeae detected in England, 2015–24: an observational analysis. Journal of Antimicrobial Chemotherapy. 2024;79(12):3332-3339. doi:10.1093/jac/dkae369
BibTeX
@article{Fifer2024,
author = {Fifer, Helen and Doumith, Michel and Rubinstein, Luciana and Mitchell, Laura and Wallis, Mark and Singh, Selena and Jagjit Singh, Gurmit and Rayment, Michael and Evans-Jones, John and Blume, Alison and Dosekun, Olamide and Poon, Kenny and Nori, Achyuta and Day, Michaela and Pitt-Kendall, Rachel and Sun, Suzy and Narayanan, Prarthana and Callan, Emma and Vickers, Anna and Minshull, Jack and Bennet, Kirsty F and Johnson, James E C and Saunders, John and Alexander, Sarah and Mohammed, Hamish and Woodford, Neil and Sinka, Katy and Cole, Michelle},
title = {Ceftriaxone-resistant Neisseria gonorrhoeae detected in England, 2015–24: an observational analysis},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2024},
volume = {79},
number = {12},
pages = {3332--3339},
doi = {10.1093/jac/dkae369}
}
EUVIMED